Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/10/04 → 12/31/19 |
Funding
- Frontier Science and Technology Research Foundation (PCOE2197 E2197 // PCOE2197 E2197)
- Aventis S.A. (PCOE2197 E2197 // PCOE2197 E2197)
ECOG PCO-RL: Phase III Study of Adriamycin/Taxotere vs. Adriamycin/Cytoxan for the Adjuvant Treatment of Node Positive or High Risk Node Negative Breast Cancer
- Yang, Ximing J (PD/PI)
Project: Research project